ANI PHARMACEUTICALS INC (ANIP) Insider Trading

Name: ANI PHARMACEUTICALS INC (ANIP) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 16, 2026): Nikhil Lalwani (PRESIDENT & CEO): Sale of 5,400 shares, $388.2K.

Get alerted when insiders trade ANIP

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta